Announcements Trials
Browse Landscape

Phase

Phase 2 67Phase 1 38Phase 3 27Phase NA 23Phase 1/2 22Phase EARLY_PHASE1 5Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 52Neoplasms, Plasma Cell 5Neoplasms 4Lymphoma 4Waldenstrom Macroglobulinemia 3Recurrence 3Hematologic Neoplasms 3Prostatic Neoplasms 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Breast Neoplasms 2Bone Neoplasms 2Back Pain 2Venous Thromboembolism 1Stomatitis 1Skin Neoplasms 1Renal Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Pain 1Osteoporosis 1Osteonecrosis 1Osteolysis 1Myeloproliferative Disorders 1Multiple Sclerosis 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1

Interventions

Thalidomide 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Immunoglobulin Light-chain Amyloidosis × Plasma cell × Clear all
NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown
70 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡